Unique to AZD3514 as a pharmacological modulator is its ability to down regulate the protein both in vitro and in vivo[6] and its anti-proliferative activity against Dunning R3327H prostate tumours in rats correlated to a reduction in AR levels in tumour tissue[6]. The gene discussed is AR; the disease is neoplasm.